Delivery Order SPE2DB25D2203-SPE2DB26FPRAN
- Not listed
- The Defense Logistics Agency awarded a delivery order contract valued at $13,892.66 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/mL SureClick auto-injectors. The contract is a firm fixed price delivery order with no set-aside designation, issued on September 12, 2025, with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $35,687.57 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. The contract, awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, operates under a firm fixed-price structure with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, with a contract ceiling value of $31,271.18. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $2,859.55 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of April 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of REPATHA 140 mg/mL SureClick auto-injectors with a ceiling value of $48,141.39. This competitively awarded, firm fixed price delivery order is not set-aside and has an ultimate completion date of August 20, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,694.18 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This competitive, firm fixed-price delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, indicating it was awarded through open competition. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,207.19 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injector medication, with an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $2,520.37 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of June 3, 2025. This is a firm fixed price, non-set-aside contract supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $40,257.94 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare...
- SPE2DB25D2203Indefinite Delivery Contract
- SPE2DB25D2203-SPE2DB26FPRANDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,009.83 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors on October 29, 2025, with completion scheduled for October 30, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting an open and competitive procurement process. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. The Defense Health Agency, U.S. Coast Guard, and other government healthcare systems benefit from this flexible contract vehicle as part of the broader Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/29/25 |